#United States #San Francisco #Rubi Technology #CO2 Materials #Enzyme Engineering

Rubi's Journey: Transforming CO2 into Essential Materials

Rubi, a pioneer in sustainable manufacturing, has recently announced a remarkable funding achievement, securing $7.5 million in its latest round and notable commercial contracts valued at over $60 million. This funding comes at a pivotal time as the company takes significant strides toward advancing its CO2-to-materials platform. The company is uniquely positioned at the forefront of a new era in manufacturing, utilizing groundbreaking enzyme technology to convert waste carbon into essential materials needed across various industries.

Fresh Funding Fuels Growth

The funding round was co-led by AP Ventures and FH One Investments, attracting contributions from notable investors such as Talis Capital, CMPC Ventures, HM Group, Understorey Ventures, and several angel investors. This financial boost is aimed at scaling Rubi's production system to an industrial demonstration level, further accelerating the commercialization of its products. The funding is expected to enhance the performance of Rubi's engineered enzymes, leading to higher efficiencies and reduced costs in production processes.

Major Commercial Validation in 2025

Rubi’s recent funding arrived on the heels of an incredibly successful year. In 2025, the company:

• - Secured multi-year offtake agreements worth over $60 million with leading fashion brands and manufacturers.
• - Expanded its commercial partnerships from seven to fifteen, doubling its network. Noteworthy partners include retail giants like Walmart and Reformation.
• - Achieved successful testing of fiber performance with multiple partners, demonstrating the viability and quality of its product offerings.
• - Initiated new pilot programs in sectors like consumer packaged goods (CPG) and aerospace, thereby broadening its market presence beyond textiles.

Visionary Leadership

Neeka Mashouf, co-founder and CEO of Rubi, expressed the company’s vision: “We started Rubi with the conviction that cell-free, multi-enzyme pathways could realize efficient and scalable manufacturing of critical materials from CO2. Our technology has been proven at scale, satisfying customer product standards and driving us to a significant commercialization point.”

With fresh capital in hand, Rubi is set to meet the increasing global demand for modular and cost-effective manufacturing practices, targeting key industries like textiles, CPG, aerospace, and chemicals.

Acknowledgements and Future Plans

In 2025, Rubi was honored on the Norrsken Impact/100 list, recognizing companies making meaningful impacts in their industries. Additionally, Mashouf earned a spot on the prestigious MIT 35 Under 35 list and had the honor of speaking at the World Economic Forum in Davos. The company's progress is further supported by the addition of six experts in biocatalysis, AI enzyme engineering, and scalable systems to its advisory board, which includes distinguished figures like Dr. Michael Jewett, Dr. Richard Fox, and Dr. Alex Patist.

Transition to Industrial Scale

Looking ahead, Rubi plans to make significant advancements in its industrial demonstration scale system. This move will enable the company to produce commercial quantities of materials for its customers in the textile and CPG formulation sectors. Kevin Eggers, a partner at AP Ventures, remarked on Rubi’s evolution, stating, “The team has successfully transitioned from a scientific platform to early commercial traction.” Therefore, Rubi is poised for substantial scaling as it capitalizes on rising demands across multiple industries.

Innovative Manufacturing Solutions

Fundamentally reshaping manufacturing, Rubi's modular production system addresses contemporary challenges such as supply chain resilience, flexibility, and reduced capital expenditures. Unlike traditional manufacturing, which relies on large fixed infrastructures, Rubi's approach requires significantly lower initial investments and allows for deployment in modular units wherever needed. This can help establish critical supply chains at the point of demand, which is a game-changer in manufacturing efficiency.

Rubi’s proprietary cell-free enzyme platform represents a significant paradigm shift in material production. By utilizing cascades of specialized enzymes, the company transforms abundant carbon materials like CO2 into valuable products such as cellulose polymers. This process allows for efficient and versatile production capabilities, achieving higher performance than conventional manufacturing methods. Further advancements in AI and machine learning are also embedded in Rubi's strategies to consistently enhance enzyme functionality, leading to improved costs and productivity benefits.

About Rubi

Founded in 2021 by Neeka Mashouf and Dr. Leila Mashouf, Rubi is dedicated to revolutionizing manufacturing. By converting waste carbon into essential materials, the company aims to create a sustainable manufacturing ecosystem that aligns with the planet's needs while enhancing industrial competitiveness. For more information, please visit www.rubi.earth.